On Monday, CytomX Therapeutics Inc (NASDAQ: CTMX) opened lower -8.51% from the last session, before settling in for the closing price of $3.88. Price fluctuations for CTMX have ranged from $0.40 to $4.62 over the past 52 weeks.
Company’s average yearly earnings per share was noted -108.84% at the time writing. With a float of $126.53 million, this company’s outstanding shares have now reached $165.07 million.
CytomX Therapeutics Inc (CTMX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CytomX Therapeutics Inc is 25.32%, while institutional ownership is 64.38%. The most recent insider transaction that took place on Nov 06 ’25, was worth 461,906. In this transaction CEO of this company sold 101,793 shares at a rate of $4.54, taking the stock ownership to the 987,891 shares. Before that another transaction happened on Nov 06 ’25, when Company’s CEO proposed sale 101,793 for $4.54, making the entire transaction worth $461,909.
CytomX Therapeutics Inc (CTMX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.23 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.11) by 0.34. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
CytomX Therapeutics Inc (NASDAQ: CTMX) Trading Performance Indicators
Check out the current performance indicators for CytomX Therapeutics Inc (CTMX). In the past quarter, the stock posted a quick ratio of 3.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.42, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of CytomX Therapeutics Inc (CTMX)
Looking closely at CytomX Therapeutics Inc (NASDAQ: CTMX), its last 5-days average volume was 3.94 million, which is a jump from its year-to-date volume of 3.41 million. As of the previous 9 days, the stock’s Stochastic %D was 32.55%.
During the past 100 days, CytomX Therapeutics Inc’s (CTMX) raw stochastic average was set at 63.10%, which indicates a significant increase from 23.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.37 in the past 14 days, which was higher than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.17, while its 200-day Moving Average is $1.97. However, in the short run, CytomX Therapeutics Inc’s stock first resistance to watch stands at $3.82. Second resistance stands at $4.08. The third major resistance level sits at $4.24. If the price goes on to break the first support level at $3.40, it is likely to go to the next support level at $3.24. Should the price break the second support level, the third support level stands at $2.98.
CytomX Therapeutics Inc (NASDAQ: CTMX) Key Stats
There are currently 169,435K shares outstanding in the company with a market cap of 601.50 million. Presently, the company’s annual sales total 138,100 K according to its annual income of 31,870 K. Last quarter, the company’s sales amounted to 5,960 K and its income totaled -14,230 K.
